U.S. Wireless Telecom Stock News

Iovance Biotherapeutics stock has delivered a sharp year to date gain, yet the valuation checks and current trading multiples point to a company that does not clearly stand out as either a bargain or a firmly overvalued outlier. For investors, the tension is between a strong recent share price move and a mixed read from the broader valuation framework. Year to date, Iovance Biotherapeutics has returned 117.5%, which puts recent momentum front and center in any discussion of what the stock is...

Options activity in Artisan Partners Asset Management (APAM) has picked up after the September 18, 2026 $21.93 call ranked among the highest implied volatility equity contracts, suggesting traders are positioning for a sizable share price move. See our latest analysis for Artisan Partners Asset Management. At a latest share price of $39.21, Artisan Partners Asset Management has seen a 9.28% 1 month share price return, while its year to date share price return is down 5.31% and the 5 year...

Honeywell International stock has just gone through a sharp pullback over the past month, while the valuation checks lean toward the shares not being a clear bargain. This sets up a tension between recent price weakness and what the broader metrics are signaling. Over the past month, Honeywell International is down 49.8%, which is a large move that forces investors to reassess whether the new price fairly reflects the fundamentals. On one side, the acquisition of Johnson Matthey’s Catalyst...

Teradyne (TER) is back in focus as Wall Street gears up for its June 2026 quarter earnings report, with expectations for significantly higher earnings per share and revenue compared with the prior year. See our latest analysis for Teradyne. Teradyne’s recent 12.07% 1 day share price gain to $374.04 comes after a softer 30 day share price return, which declined 14.59%. However, the year to date share price return of 80.21% and 1 year total shareholder return of around 4x suggest momentum has...

PriceSmart earnings: what the latest figures tell investors PriceSmart (PSMT) recently reported third quarter and nine month results that showed higher revenue and net income compared with the same periods a year earlier, putting fresh focus on the stock after the filing. For the third quarter ended May 31, 2026, PriceSmart reported revenue of US$1,481.79 million and net income of US$39.69 million, with basic and diluted earnings per share from continuing operations of US$1.28. See our latest...

Covenant Logistics Group (CVLG) has drawn fresh attention after a strong recent share price move, with the stock up 2.9% in the past day and 7.4% over the past week. See our latest analysis for Covenant Logistics Group. That short-term jump in Covenant Logistics Group’s share price sits on top of a much stronger trend, with a 30-day share price return of 17.01% and a year-to-date share price return of 123.68%. The 1-year total shareholder return of 108.92% and 5-year total shareholder return...

PagSeguro Digital (NYSE:PAGS) has drawn investor attention after recent share price moves, prompting a closer look at how its current trading levels compare with reported earnings, revenue and its broader performance record. See our latest analysis for PagSeguro Digital. At the latest share price of $9.58, PagSeguro Digital has seen short term momentum pick up, with a 1 month share price return of 8.62%, even though the 3 month share price return is down 10.97% and the 5 year total...

Oil prices have surged after renewed U.S. military action against Iran and rising tensions around the Strait of Hormuz, with Brent above $94 a barrel and WTI over $87. When crude jumps, it can reshuffle winners and losers across the stock market, from producers and traders to firms tied to oil-linked financial instruments. This article looks at how the latest geopolitical shock is feeding into that reshuffle and what it might mean for investors weighing exposure to oil price moves. Ahead, you...

NIO’s share price has fallen about 88% over the past five years, yet valuation checks now show a mixed picture, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model sitting close to the current price while market multiples still screen the stock as undervalued. Over five years, NIO is down about 88%, which means any valuation case today is being made against a backdrop of very weak long-term returns. Analyst optimism around stronger vehicle deliveries, higher margins and...

Earlier this month, Forte Biosciences reported positive double-blind, placebo-controlled phase 1b results for FB102 in vitiligo, showing statistically significant facial repigmentation and a favorable safety profile across 43 patients. Importantly, many FB102-treated subjects continued to improve even after the 12-week dosing period ended, suggesting a potentially durable treatment effect out to week 24. We will now examine how FB102’s statistically significant FVASI improvement and...

Earlier in 2026, Coeur Mining, Inc. announced an update on its exploration programs at the Palmarejo and Las Chispas gold-silver operations in Mexico, committing US$158 million to its largest-ever drilling budget focused on resource growth and mine life extension. The company highlighted especially strong drilling results in Palmarejo’s Eastern District and the Gap Zone at Las Chispas, pointing to the potential for meaningful near-term reserve additions and a stronger long-term production...

Recent analyst commentary highlighted Vistra’s strong earnings outlook, with multiple upward estimate revisions and a top Zacks Rank reflecting broad research-house optimism in the period leading up to today. What stands out is the unusually high concentration of bullish ratings, with most covering brokerages placing Vistra in their strongest recommendation category based on earnings expectations and asset utilization trends. Next, we’ll examine how this heightened analyst confidence in...

Fortinet global distributor designation puts TD SYNNEX in focus TD SYNNEX (SNX) is in the spotlight after being named one of Fortinet Inc.'s approved global distributors, a move that broadens its role in supporting large systems integrators and multinational partners. The designation allows TD SYNNEX to coordinate Fortinet related projects across regions. This helps partners manage multi country deployments through centralized logistics, standardized operational support and access to its...

MSCI Inc. has reported its second-quarter 2026 results, with sales rising to US$867 million from US$772.7 million a year earlier and net income increasing to US$342 million from US$303.7 million, alongside higher earnings per share. Alongside these results, MSCI highlighted expanding AI-led tools, new product launches, and a growing private-markets platform, signaling a deeper push into data and analytics for less transparent asset classes. Next, we’ll examine how MSCI’s strong earnings and...

Sprouts Farmers Market stock has delivered a strong 202.5% return over the past 5 years, yet its current checks still point to shares screening as undervalued on several key measures. Over 5 years, Sprouts Farmers Market has returned 202.5%, which puts the recent pullback into context as a longer term compounding story rather than a short term trade. For valuation, the main support can come from the company sustaining healthy cash generation and margins, while a key risk is any pressure on...

Recent performance context for Dillard's stock Dillard's (DDS) has seen mixed share performance recently, with the stock up over the past day and month, but down over the past 3 months and year to date, prompting closer attention from investors. See our latest analysis for Dillard's. At the current share price of $568.27, Dillard's has posted a 7.75% 7 day share price return and a 2.42% 30 day share price return, but the 90 day share price return is down 6.69% and the year to date share price...

We feel now is a pretty good time to analyse BioHarvest Sciences Inc.'s ( NASDAQ:BHST ) business as it appears the...

Bristol-Myers Squibb (BMY) is back in focus after the FDA accepted its New Drug Application for mezigdomide in relapsed or refractory multiple myeloma, alongside a new AI collaboration with Nvidia for drug discovery. See our latest analysis for Bristol-Myers Squibb. The recent FDA filing for mezigdomide and the AI expansion with Nvidia come as Bristol-Myers Squibb’s share price has gained momentum, with a 12.83% 1 month share price return and 13.97% year to date, while the 1 year total...

Bank of America recently added Keurig Dr Pepper (KDP) to its U.S. 1 List, drawing fresh attention to the beverage company’s stock and its mix of coffee, soft drinks, and other consumer drinks. See our latest analysis for Keurig Dr Pepper. The recent addition of Keurig Dr Pepper to Bank of America’s U.S. 1 List comes after a period where the stock’s 90 day share price return rose 13.83%, while its 1 year total shareholder return declined 7.56%. This combination suggests improving short term...

Bitdeer Technologies Group (NasdaqCM:BTDR) recently reported unaudited June 2026 operating metrics that highlighted record Bitcoin production, a larger managed hash rate base, and progress on AI infrastructure and hardware manufacturing projects across multiple regions. See our latest analysis for Bitdeer Technologies Group. The June update and recent AI and manufacturing projects come after a mixed share price run for Bitdeer Technologies Group, with a 1-day share price return of 9.76%, a...

We'd be surprised if The Greenbrier Companies, Inc. ( NYSE:GBX ) shareholders haven't noticed that the Senior VP...

The investors in Frequency Electronics, Inc. 's ( NASDAQ:FEIM ) will be rubbing their hands together with glee today...

In July 2026, Summit Therapeutics Inc. announced it had signed an agreement with Toronto-based Biossil Inc. to sell ridinilazole, its Phase III investigational precision antibiotic, for US$500,000 upfront plus up to US$104.5 million in potential regulatory and commercial milestones and tiered royalties on future net sales. This transaction effectively monetizes a non-core antibiotic asset, potentially allowing Summit to redirect capital and management focus toward its oncology programs...

Morgan Stanley recently raised concerns about Vertex’s ability to reach its end-market potential amid a transition period and rising artificial intelligence pressures in tax compliance technology. The commentary highlights that AI is emerging not just as a tool but also as a competitive threat that could reshape the tax automation landscape for Vertex. We’ll now examine how Morgan Stanley’s AI-related growth concerns may influence Vertex’s existing investment narrative around...